Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin
Introduction | Browse | Search | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01030159 | 11,14,17-eicosatrienoic acid | Lipid-depleted/compactin | 0.0 | BCD100322A002 | 0.87 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | Lipid-depleted/compactin | 0.5 | BCD100322A005 | 0.97 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | Lipid-depleted/compactin | 1.0 | BCD100322A009 | 0.69 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | Lipid-depleted/compactin | 2.0 | BCD100322A013 | 1.72 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | Lipid-depleted/compactin | 4.0 | BCD100322A017 | 1.87 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | Lipid-depleted/compactin | 8.0 | BCD100322A021 | 1.45 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | Lipid-depleted/compactin | 12.0 | BCD100322A025 | 1.93 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | Lipid-depleted/compactin | 24.0 | BCD100322A029 | 4.75 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | C | 0.0 | BCD100322A001 | 0.77 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | C | 0.5 | BCD100322A003 | 0.88 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | C | 1.0 | BCD100322A007 | 0.95 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | C | 2.0 | BCD100322A011 | 0.81 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | C | 4.0 | BCD100322A015 | 1.09 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | C | 8.0 | BCD100322A019 | 0.95 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | C | 12.0 | BCD100322A023 | 2.16 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | C | 24.0 | BCD100322A027 | 3.18 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A006 | 1.13 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A010 | 0.61 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A014 | 1.36 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A018 | 1.91 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A022 | 1.23 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A026 | 1.19 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A030 | 2.01 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol | 0.5 | BCD100322A004 | 0.36 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol | 1.0 | BCD100322A008 | 0.6 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol | 2.0 | BCD100322A012 | 0.48 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol | 4.0 | BCD100322A016 | 1.69 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol | 8.0 | BCD100322A020 | 0.55 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol | 12.0 | BCD100322A024 | 1.28 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol | 24.0 | BCD100322A028 | 1.95 | pmol/ug DNA |